Physiologically Active Compounds Based on Membranotropic Cage Carriers-Derivatives of Adamantane and Polyhedral Boron Clusters (Review)

被引:54
作者
Avdeeva, V. V. [1 ]
Garaev, T. M. [2 ]
Malinina, E. A. [1 ]
Zhizhin, K. Yu. [1 ]
Kuznetsov, N. T. [1 ]
机构
[1] Russian Acad Sci, Kurnakov Inst Gen & Inorgan Chem, Moscow 119991, Russia
[2] Minist Hlth Russian Federat, Gamaleya Fed Res Ctr Epidemiol & Microbiol, Moscow 123098, Russia
基金
俄罗斯基础研究基金会;
关键词
boron cluster anions; closo-borohydride anions; borohydrides; cage structures; adamantane; antiviral activity; amino acids; DICARBA-CLOSO-DODECABORANE; VITRO ANTIVIRAL ACTIVITY; NEUTRON-CAPTURE THERAPY; IN-VITRO; ANTIMICROBIAL ACTIVITY; DECABORATE ANION; ION-CHANNEL; VIRUS; INHIBITORS; CHEMISTRY;
D O I
10.1134/S0036023622010028
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
Data on compounds based on cage structures?boron clusters (polyhedral boron hydrides, carboranes, metallacarboranes) and compounds of the adamantane series, which possess physiological activity, have been generalized. The main emphasis is placed on the antiviral activity of the compounds. The mechanism of the possible action of the replication inhibitors of influenza A virus strains is considered, the molecular model of viroporin inhibitors is discussed. The proposed model consists of a cage hydrophobic core that performs the function of a membranotropic carrier (a boron cluster or adamantane fragment), into which physiologically active functional groups are introduced. The relationship between the structure of the cage compound with the introduced substitute and the biologically active properties of this molecular structure has been analyzed.
引用
收藏
页码:28 / 47
页数:20
相关论文
共 96 条
[1]   Anti-mycobacterial activity of thymine derivatives bearing boron clusters [J].
Adamska, Anna ;
Rumijowska-Galewicz, Anna ;
Ruszczynska, Anna ;
Studzinska, Miroslawa ;
Jabionska, Agnieszka ;
Paradowska, Edyta ;
Bulska, Ewa ;
Munier-Lehmann, Helene ;
Dziadek, Jaroslaw ;
Lesnikowski, Zbigniew J. ;
Olejniczak, Agnieszka B. .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2016, 121 :71-81
[2]  
Adamska A, 2012, ACTA POL PHARM, V69, P1218
[3]   Catalysts Containing the Adamantane Scaffold [J].
Agnew-Francis, Kylie A. ;
Williams, Craig M. .
ADVANCED SYNTHESIS & CATALYSIS, 2016, 358 (05) :675-700
[4]   In vitro and in vivo BNCT investigations using a carborane containing sulfonamide targeting CAIX epitopes on malignant pleural mesothelioma and breast cancer cells [J].
Alberti, Diego ;
Michelotti, Alessia ;
Lanfranco, Alberto ;
Protti, Nicoletta ;
Altieri, Saverio ;
Deagostino, Annamaria ;
Geninatti Crich, Simonetta .
SCIENTIFIC REPORTS, 2020, 10 (01)
[5]   ANTIVIRAL AGENTS .2. STRUCTURE-ACTIVITY RELATIONSHIPS OF COMPOUNDS RELATED TO 1-ADAMANTANAMINE [J].
ALDRICH, PE ;
HERMANN, EC ;
MEIER, WE ;
PAULSHOCK, M ;
PRICHARD, WW ;
SYNDER, JA ;
WATTS, JC .
JOURNAL OF MEDICINAL CHEMISTRY, 1971, 14 (06) :535-+
[6]   Boron Chemistry for Medical Applications [J].
Ali, Fayaz ;
Hosmane, Narayan S. ;
Zhu, Yinghuai .
MOLECULES, 2020, 25 (04)
[7]  
Andronova V. L., 1996, Antibiotiki i Khimioterapiya, V41, P26
[8]  
Anfimov P. M., 2010, MOL MED
[9]   Viroporin Activity of the Foot-and-Mouth Disease Virus Non-Structural 2B Protein [J].
Ao, Da ;
Guo, Hui-Chen ;
Sun, Shi-Qi ;
Sun, De-Hui ;
Fung, To Sing ;
Wei, Yan-Quan ;
Han, Shi-Chong ;
Yao, Xue-Ping ;
Cao, Sui-Zhong ;
Liu, Ding Xiang ;
Liu, Xiang-Tao .
PLOS ONE, 2015, 10 (05)
[10]   Amantadine as a drug to mitigate the effects of COVID-19 [J].
Aranda Abreu, Gonzalo Emiliano ;
Hernandez Aguilar, Maria Elena ;
Herrera Covarrubias, Deissy ;
Rojas Duran, Fausto .
MEDICAL HYPOTHESES, 2020, 140